QPharma Announces Acquisition of Qforma

QPharma, a provider of compliance and commercial services to the life sciences industry, has announced the acquisition of Qforma, Inc., a BelHealth Investment Partners portfolio company. The Morris Plains, NJ-based firm offers an array of life sciences solutions that include healthcare analytics, predictive modeling, and product launch services.

The purchase of Qforma is a natural progression of the incremental growth strategy that has served QPharma well in the past two decades,” said QPharma President and CEO Patrick Den Boer. “The outstanding technology platform and solution base they have built is a perfect complement to QPharma’s suite of business intelligence tools.”

“We are pleased to see this transaction come to fruition,” added Inder Tallur, Managing Director of BelHealth. “We believe this acquisition will enable QPharma to deliver outstanding value-added services, to the benefit of its growing roster of valued clients.”

To avoid name confusion, the Qforma brand will be phased out, and the company will continue to operate as QPharma. With the purchase, QPharma will increase its headcount by 10 percent, with new sales, strategy, and technology personnel based at offices throughout the United States. The company expects to announce updates on its enhanced set of services in the coming months.